👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

British mid-caps rise on hopes of Brexit deal this week

Published 15/10/2019, 12:40
British mid-caps rise on hopes of Brexit deal this week
UK100
-
LLOY
-
VSVS
-
HAYS
-
RSW
-
MARS
-
FTMC
-
FTNMX402020
-
INDV
-
INOV
-

By Shashwat Awasthi

(Reuters) - Britain's domestically focussed mid-cap index advanced on Tuesday amid hopes that a Brexit deal could be clinched this week, though gains were capped by steep falls in the shares of a slew of companies as the latest earnings season kicked off.

The FTSE 250 (FTMC), which had surged more than 4% last Friday after positive Brexit signals from Ireland, added 0.3% by 0800 GMT.

JP Morgan's UK domestic plays index , which tracks about 30 UK stocks that make all or most of their revenue at home, rose 1%. The index has gained more than 10% since September.

The FTSE 100 (FTSE) also inched 0.2% higher, helped by domestic banks such as Lloyds (L:LLOY), and stocks considered most sensitive to any Brexit fallout such as housebuilders (FTNMX3720) and consumer goods firms.

Britain and the European Union are set for crunch Brexit talks at a summit on Thursday and Friday, with Prime Minister Boris Johnson intent on delivering Brexit on Oct. 31 and the EU still looking for further concessions.

"Last week's observation that watching from the sidelines could be the smartest investment strategy of the year, probably still holds water this week," Oanda analyst Jeffrey Halley said.

Initial optimism surrounding U.S.-China trade was tempered and traders looked for more concrete details to assess any progress the countries had made last week to end their spat.

Any prospect of a rally among mid-caps was quelled, as downbeat trading updates led pub operator Marston's (L:MARS), industrial process furnace and ovens maker Vesuvius (L:VSVS) and engineering group Renishaw (L:RSW) 8% to 10% lower.

Marston's warned on its annual profit, while Vesuvius and Renishaw pointed to tough market conditions hitting their financials.

Indivior (L:INDV), whose shares have more than halved in value this year, jumped 12% after the drugmaker raised its annual sales and profit view.

However, Woodford Patient Capital Trust (L:WPCT) tumbled 7% to a fresh record low after the corporate director of money manager Neil Woodford's suspended LF Woodford Equity Income Fund said the fund is to be wound up.

"The career of Neil Woodford as stock-picker par excellence has come to an ignominious end," Markets.com analyst Neil Wilson said.

Ryan Hughes, head of active portfolios at AJ Bell, said it was highly unlikely that Woodford would remain manager of WPCT.

Recruiter Hays (L:HAYS) was a bright spot, jumping 6% as strong hiring in the U.S. and China offset a drop in the United Kingdom.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.